Reza Mahdavi

Reza Mahdavi

Auto-generated profile, based on publicly available information

Reza Mahdavi

Nutrition Research Center, Department of Biochemistry and Diet Therapy, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2008 in Maternal and Child Health Journal
Verified
Journal Article
Closed access
PDF file
RMR. Mahdavi
R. Mahdavi
LNL. Nikniaz
L. Nikniaz
SAS. R. Arefhosseini
S. R. Arefhosseini
MJM. Vahed Jabbari
M. Vahed Jabbari

7 March 2014 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
SPSamira Pourmoradian
Samira Pourmoradian
RMReza Mahdavi
Reza Mahdavi
MMMajid Mobasseri
Majid Mobasseri
EFElnaz Faramarzi
Elnaz Faramarzi
MMMehrnoosh Mobasseri
Mehrnoosh Mobasseri

15 August 2014 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
NAN. Mesri Alamdari
N. Mesri Alamdari
RMR. Mahdavi
R. Mahdavi
NRneda Roshanravan
neda Roshanravan
NYN. Lotfi Yaghin
N. Lotfi Yaghin
AOA. R. Ostadrahimi
A. R. Ostadrahimi
EFE. Faramarzi
E. Faramarzi
Obesity, the global epidemic health problem, results in chronic disorders. Melatonin supplementation may prevent the adverse health consequences of obesity. The aim of this study was to assess the effects of melatonin supplementation on inflammatory and oxidative stress parameters in obese women. In randomized, double-blind, placebo-controlled trial, 44 obese women were randomly assigned to melatonin (n=22) and placebo (n=22) groups. Subjects were supplemented with a daily dose of 6 mg melatonin or placebo with low calorie diet for 40 days. Serum TNF-α, IL-6, hsCRP, TAC, and MDA levels were assessed before and after intervention. In the melatonin group, mean serum TNF-α, IL-6, hsCRP, and MDA levels decreased significantly (p<0.05) from 3.52±0.72 pg/ml, 27.12±6.32 pg/ml, 2.54±0.49 mg/l, and 3.81±0.29 nmol/l to 1.73±0.07, 16.34±6.32, 1.67±0.27, and 2.79±0.29, respectively. Whilst in the placebo group the decrease in values were not statistically significant. Mean TAC level increased slightly (from 1.11±0.30 to 1.14±0.45 mmol/l) in the melatonin group whereas it decreased slightly (from 1.13±0.15 to 1.08±0.21 nmol/l) in the placebo group. Significant differences were observed only for TNF-α (p=0.02) and IL-6 (p=0.03) between the 2 study groups. Considering the improvements in inflammatory and oxidative stress factors in obese women, it seems that melatonin supplementation may provide beneficial effects in obesity treatment by ameliorating some of its complications. However, further studies are needed to make concise conclusions.

17 August 2012 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
AEAli Tarighat Esfanjani
Ali Tarighat Esfanjani
RMReza Mahdavi
Reza Mahdavi
MEMehrangiz Ebrahimi-Mameghani
Mehrangiz Ebrahimi-Mameghani
MTMahnaz Talebi
Mahnaz Talebi
ZNZeinab Nikniaz
Zeinab Nikniaz
ASAbdolrasool Safaiyan
Abdolrasool Safaiyan

15 May 2015 in Food & Function
Verified
Journal Article
Closed access
PDF file
RMReza Mahdavi
Reza Mahdavi
NNNazli Namazi
Nazli Namazi
MAMohammad Alizadeh
Mohammad Alizadeh
SFSafar Farajnia
Safar Farajnia
Obesity is typically associated with increased risk factors of cardiovascular diseases (CVDs). Therefore, a therapeutic approach that aims to control body weight and metabolic profile might be effective in preventing CVDs. We aimed to determine the effects of Nigella Sativa (NS) oil with a low-calorie diet on cardiometabolic risk factors in obese women. In this double-blind randomized controlled clinical trial, 90 obese women were recruited. Participants were females aged 25–50 years old with body mass index (BMI) between 30 and 35 kg m−2. They were randomly assigned to receive a low-calorie diet with 3 g per day (1 g before each meal) NS oil or placebo for 8 weeks. Anthropometric indices, dietary intake and biochemical parameters were measured at the baseline and after the intervention. Eighty-four females completed the trial (intervention n = 43, placebo n = 41). Two groups were similar in the baseline characteristics. After the intervention, dietary intake was changed in both groups compared to the baseline, but the differences were not significant between the two groups. In the NS group, weight (−6.0 vs. −3.6%; p < 0.01) and waist circumference (−6.9 vs. −3.4%; p < 0.01) decreased significantly compared with the placebo group at the end of the trial. Comparison of biochemical parameters presented a significant decline in triglyceride (−14.0 vs. 1.4%; p = 0.02) and very low density lipoprotein (−14.0 vs. 7%; p < 0.01) levels in the NS group compared to the placebo group. NS oil concurrent with a low-calorie diet can reduce cardiometabolic risk factors in obese women. However, more clinical trials are needed to elucidate efficacy of NS as a complementary therapy in obese subjects.

30 June 2013
Verified
Journal Article
Open access
NSNasrin Sharifi
Nasrin Sharifi
RMReza Mahdavi
Reza Mahdavi
MEMehrangiz Ebrahimi-Mameghani
Mehrangiz Ebrahimi-Mameghani
Background: In order to develop appropriate obesity control and treatment strategies, the key point is to understand the barriers perceived by overweight or obese people in trying to follow weight-loss programs. This study examined perceived barriers to weight-loss programs among overweight or obese women.